Generic drugmakers to sell Pfizer’s Paxlovid for $25 or less in low-income countries

Several generic drugmakers that will produce versions of Pfizer’s COVID-19 antiviral treatment Paxlovid have agreed to sell the medicine in low- and middle-income countries for $25 a course or less, the Clinton Health Access Initiative (CHAI) said on Thursday.

Related Posts

Leave a Reply

Your email address will not be published.